Finance

Lists
Why is ALGS up 6.06%?
Dive Deeper
ALGS:NASDAQ
Aligos Therapeutics Inc
$2.10
+6.06%
(+0.12) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALGS...
Open
$2.09
High
$2.24
Low
$1.98
Mkt. cap
13.12M
Avg. vol.
54.79K
Volume
57.52K
52-wk high
$13.69
52-wk low
$1.92
EPS
-$6.36
Beta
2.43
Shares outstanding
5.44M
No. of employees
82
Open
$2.09
High
$2.24
Low
$1.98
Mkt. cap
13.12M
Avg. vol.
54.79K
Volume
57.52K
52-wk high
$13.69
52-wk low
$1.92
EPS
-$6.36
Beta
2.43
Shares outstanding
5.44M
No. of employees
82
News stories
From web sources and news partners
About Aligos Therapeutics Inc
CEO-
Employees82
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorHealth Care
IndustryBiotechnology
Websitealigos.com
Analyst ratings
Based on 1 analyst giving stock ratings to ALGS in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ALGS in the last 3 months
Highest
Current $2.10
$50.00 (+2,280.95%)
Average
$50.00 (+2,280.95%)
Lowest
$50.00 (+2,280.95%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$50.00
+2,281%
11/11/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$175.00
+8,233.3%
08/07/2026
Daniel Brims
Lake Street
Buy
Reiterated
$45.00
+2,042.9%
08/07/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$20.00
+852.4%
08/06/2026
David Siffringer
Cantor Fitzgerald
Buy
Initiated
$20.00
+852.4%
05/21/2026
Anthea Li
Jefferies
Buy
Initiated
$48.00
+2,185.7%
03/19/2026
Unknown Analyst
Jefferies
Buy
Initiated
$48.00
+2,185.7%
03/19/2026
Michael Yee
UBS
Buy
Maintained
$20.00
+852.4%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
169.00K
2.83M
27.78M
2.87M
Cost of goods sold
17.04M
23.35M
24.05M
-
Cost of revenue
17.04M
23.35M
24.05M
-
Research and development expenses
-
-
-
18.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.94M
6.41M
5.62M
5.87M
Operating expense
4.94M
6.41M
5.62M
24.76M
Total operating expenses
21.98M
29.76M
29.67M
24.76M
Operating income
-21.81M
-26.93M
-1.89M
-21.89M
Other non operating income
1.22M
4.07M
2.95M
356.00K
EBT including unusual items
-19.85M
-22.72M
1.31M
-21.53M
EBT excluding unusual items
-19.85M
-22.72M
1.31M
-21.53M
Income tax expense
30.00K
317.00K
2.81M
326.00K
Effective tax rate
-0.15%
-1.40%
215.07%
-1.51%
Other operating expenses
-
-
-
-
Net income
-19.88M
-23.04M
-1.50M
-21.86M
Net profit margin
-11,763.91%
-814.13%
-5.41%
-761.94%
Earnings per share
-1.91
-2.21
-0.14
-2.09
Interest and investment income
548.00K
140.00K
246.00K
-
Interest expense
-
-
-
-
Net interest expenses
548.00K
140.00K
246.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.56M
-26.58M
-1.64M
-21.64M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps